Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 24, 2020
Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patientsBastien Misgault, Eva Chatron, Quitterie Reynaud, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2020
Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1-Infected West African Adults With High CD4 CountsRoseline Affi, Delphine Gabillard, Catherine Dunyach-Remy, et al.
Journal of Clinical Medicine|November 13, 2020
First Wave of COVID-19 in French Patients with Cystic FibrosisHarriet Corvol, Sandra de Miranda, Lydie Lemonnier, et al.
AIDS (London, England)|February 4, 2012
Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIVYves Lévy, Rodolphe Thiébaut, Marie-Lise Gougeon, et al.
NPJ Vaccines|June 25, 2019
HIV therapeutic vaccine enhances non-exhausted CD4<sup>+</sup> T cells in a randomised phase 2 trialVincent Vieillard, Béhazine Combadière, Roland Tubiana, et al.
European Journal of Pediatrics|November 30, 2022
Long-term evolution of neuroendocrine cell hyperplasia of infancy: the FRENCHI findingsMorgane Dervaux, Caroline Thumerelle, Candice Fabre, et al.
European Journal of Pediatrics|June 9, 2022
French national cohort of neuroendocrine cell hyperplasia of infancy (FRENCHI) study: diagnosis and initial managementCandice Fabre, Caroline Thumerelle, Morgane Dervaux, et al.
Pageof 14